Former CEO of Insys Therapeutics Sentenced for Racketeering Scheme
Outcome
OIG enforcement action against Former CEO of Insys Therapeutics Sentenced for Racketeering Scheme for false claims, controlled substance.
Details
Former CEO of Insys Therapeutics Sentenced for Racketeering Scheme — OIG Enforcement (2026)
OIG took enforcement action against Former CEO of Insys Therapeutics Sentenced for Racketeering Scheme in 2026 involving false claims, controlled substance violations in the Healthcare General sector.
Violation types: False Claims, Controlled Substance
Entity type: Healthcare Provider
Penalty type: Criminal
Source: Former CEO of Insys Therapeutics Sentenced for Racketeering Scheme
How Crucible Prevents This
Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery. Crucible's controlled substance tracking enforces DEA-compliant inventory reconciliation, flags prescribing pattern anomalies, and requires segregation of duties for dispensing and record-keeping.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works